Lantheus Holdings (LNTH) Current Taxes (2024 - 2026)

Lantheus Holdings (LNTH) posted quarterly Current Taxes of $22.1 million for Q1 2026, up 519.61% quarter-over-quarter from $3.6 million in Q4 2025.

Lantheus Holdings (LNTH) Current Taxes (2024 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Current Taxes for 3 consecutive years, with $22.1 million the latest figure, recorded in Q1 2026.

In Q1 2026, Current Taxes changed N/A year-over-year to $22.1 million; the TTM figure through Mar 2026 stood at $22.1 million (changed N/A YoY), while the FY2025 annual figure was $3.6 million, up 124.64% from the prior year.
Current Taxes improved to $22.1 million in Q1 2026 per LNTH's latest filing, from $3.6 million in the prior quarter.
Across five years, Current Taxes topped out at $22.1 million in Q1 2026 and bottomed at $1.4 million in Q3 2025.
Historically, Current Taxes has averaged $6.0 million across 3 years, with a median of $1.6 million in 2024.
On a YoY basis, Current Taxes climbed as much as 124.64% in 2025 and fell as far as 124.64% in 2025.
Lantheus Holdings' Current Taxes stood at $1.6 million in 2024, then jumped by 124.64% to $3.6 million in 2025, then surged by 519.61% to $22.1 million in 2026.
Business Quant data shows LNTH's Current Taxes at $22.1 million in Q1 2026, $3.6 million in Q4 2025, and $1.4 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-355.54 Mn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	138.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	739.89 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	46.00 Mn
10	Lantheus Holdings	6.54 Bn	5.94 Bn	241.86 Mn	4.03 Mn

Download Data